Bharat Biotech inks pact with Precisa Med to supply Covaxin to Brazil

Sumit Arora Last updated on January 13th, 2021 12:35 pm Leave a comment

Bharat Biotech has announced that it has signed an agreement with Precisa Medicamentos for the supply of its indigenously manufactured Covid-19 vaccine ‘Covaxin’ to Brazil. The supplies of Covaxin will be prioritized for the public market, through direct procurement by Brazil government.

WARRIOR 4.0 | Banking Awareness Batch for SBI, RRB, RBI and IBPS Exams | Bilingual | Live Class

A team from Precisa Medicamentos had visited the Bharat Biotech facility in Genome Valley near here last week to discuss export of COVAXIN, India’s first indigenous vaccine for Covid-19.

Important takeaways for all competitive exams:

Bharat Biotech Founded: 1996.
Bharat Biotech Headquarters location: Hyderabad.
Bharat Biotech Executive director: Dr V Krishna Mohan.

Find More News Related to Agreements

About the Author

Sumit Arora

Author

As a team lead and current affairs writer at Adda247, I am responsible for researching and producing engaging, informative content designed to assist candidates in preparing for national and state-level competitive government exams. I specialize in crafting insightful articles that keep aspirants updated on the latest trends and developments in current affairs. With a strong emphasis on educational excellence, my goal is to equip readers with the knowledge and confidence needed to excel in their exams. Through well-researched and thoughtfully written content, I strive to guide and support candidates on their journey to success.